Daojun Hu

Mr. Daojun Hu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

29 April 2016 in Scientific Reports
Verified
Journal Article
Open access
YXYang Xuan
Yang Xuan
XLXiao-Hong Li
Xiao-Hong Li
ZHZhong-Qian Hu
Zhong-Qian Hu
ZTZhi-Mei Teng
Zhi-Mei Teng
DHDaojun Hu
Daojun Hu
Observational studies have demonstrated an association between elevated homocysteine (Hcy) level and risk of multiple myeloma (MM). However, it remains unclear whether this relationship is causal. We conducted a Mendelian randomization (MR) study to evaluate whether genetically increased Hcy level influences the risk of MM. We used the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism as an instrumental variable, which affects the plasma Hcy levels. Estimate of its effect on plasma Hcy level was based on a recent genome-wide meta-analysis of 44,147 individuals, while estimate of its effect on MM risk was obtained through meta-analysis of case-control studies with 2,092 cases and 4,954 controls. By combining these two estimates, we found that per one standard-deviation (SD) increase in natural log-transformed plasma Hcy levels conferred a 2.67-fold increase in risk for MM (95% confidence interval (CI): 1.12–6.38; P = 2.7 × 10−2). Our study suggests that elevated Hcy levels are causally associated with an increased risk of developing MM. Whether Hcy-lowering therapy can prevent MM merits further investigation in long-term randomized controlled trials (RCTs).

1 November 2020
Verified
Journal Article
Closed access
DHDaojun Hu
Daojun Hu
BSBaoyan Shen
Baoyan Shen
MYMiao Yu
Miao Yu
XZXiaoyin Zha
Xiaoyin Zha
YZYe Zhou
Ye Zhou
DHDaojun Hu
Daojun Hu